
LifeSciences BC is a industry association that supports and represents the life sciences community of British Columbia in Canada.

The National Health Commission announced new food ingredients and additives are permitted to be used in food-contact articles.

On November 26, 2020, the SAMR announced the temporary measures for on-site inspection on special food products in China.

Five health food ingredients to be filed according to the directory and technical requirements for raw materials from March 1, 2021 onwards.

The NMPA announced various updates regarding soap, toothpaste, hair removal, hair growth, breast beauty, body slimming and deodorizing products.

The NIFDC released 7 technical draft proposals for detecting chemical agents and the evaluation of efficacy claims in cosmetic products in China.

Ultrasonic coupling agents are reminded to comply with mandatory standards and any necessary filing changes must be completed by the end of February 2021.

The new draft clarifies the registration requirements and categorization method of different drug-device combination products in China.

3 GB standards announced; 14 technical guidelines and 2 draft guidelines were issued; 6 medical devices pending for fast-track approval

Due to the 2020 performance of the fast-track approval process for medical device registration in China, the CDME plans to implement a smart review process.

The China SAMR published the new ordinance TSG 23 covering previous regulations such as TSG R1003-2006, TSG R4001-2006, TSG R7002-2009, and TSG R7003-2011.

The MTC bundles the potential and expertise of our partners, increasing the innovative strength and international competitiveness of each individual company

The SAMR issued the 2020 directory of health food raw materials and nutrient supplements, expanding the number of approved health claims.

The NMPA issued guidelines to address the standard procedure of submitting risk evaluation reports after the occurrence of adverse events.

The CMDE shared a timeline of events for establishing regulatory control on AI medical devices and shared the latest status of their upcoming plans.

The State Administration for Market Regulation addressed the innovative development plan actions for drugs and medical devices in the Greater Bay Area.

China’s NMPA issues technical guidelines (trial) for utilizing real-world data (RWD) in the medical device clinical evaluation process.

Following the launch of the China’s national UDI system, the Hainan MPA has announced a pilot plan for the UDI system in Hainan with a larger product scope.

The new ordinance TSG 11 (Revision 2020) for safety technology for boilers was published with Notice 45/2020 of the authority SAMR.

The SAMR issued technical guidelines concerning toxicology, strains used, physicochemical properties and hygienic indicators for health food products
And discover how we can support you.